We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticles Bring Big Improvement to Imaging Technology

By LabMedica International staff writers
Posted on 21 Dec 2009
New imaging research makes it possible to examine processes that occur over hours or even days inside cells, potentially solving many of the mysteries associated with molecular-scale events. More...


A joint research team, working at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) and the U.S. National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD, USA), has discovered a method of using nanoparticles to illuminate the cellular interior to reveal these slow processes. Nanoparticles, thousands of times smaller than a cell, have a variety of applications. One type of nanoparticle called a quantum dot glows when exposed to light. These semiconductor particles can be coated with organic materials, which are engineered to be attracted to specific proteins within the part of a cell a scientist wishes to examine.

"Quantum dots last longer than many organic dyes and fluorescent proteins that we previously used to illuminate the interiors of cells,” said biophysicist Dr. Jeeseong Hwang, who led the team on the NIST side. "They also have the advantage of monitoring changes in cellular processes while most high-resolution techniques like electron microscopy only provide images of cellular processes frozen at one moment. Using quantum dots, we can now elucidate cellular processes involving the dynamic motions of proteins.”

For their recent study, the researchers relied principally on characterizing quantum dot properties, contrasting them with other imaging techniques. In one example, they employed quantum dots designed to target a specific type of human red blood cell protein that forms part of a network structure in the cell's inner membrane. When these proteins cluster together in a healthy cell, the network provides mechanical flexibility to the cell so it can squeeze through narrow capillaries and other tight spaces. But when the cell becomes infected with the malaria parasite, the structure of the network protein changes.

"Because the clustering mechanism is not well understood, we decided to examine it with the dots,” said NIAID biophysist Fuyuki Tokumasu. "We thought if we could develop a technique to visualize the clustering, we could learn something about the progress of a malaria infection, which has several distinct developmental stages.”

The research team's efforts revealed that as the membrane proteins bunch up, the quantum dots attached to them are induced to cluster themselves and glow more brightly, permitting scientists to watch as the clustering of proteins progresses. More broadly, the investigators found that when quantum dots attach themselves to other nanomaterials, the dots' optical properties change in unique ways in each case. They also discovered evidence that quantum dot optical properties are altered as the nanoscale environment changes, offering greater possibility of using quantum dots to sense the local biochemical environment inside cells.

"Some concerns remain over toxicity and other properties,” Dr. Hwang said, "but altogether, our findings indicate that quantum dots could be a valuable tool to investigate dynamic cellular processes.”

The study was published November 2009 in the early online edition of the journal WIREs Nanomedicine and Nanobiotechnology.

Related Links:
U.S. National Institute of Standards and Technology
U.S. National Institute of Allergy and Infectious Diseases





New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.